| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 70,633 | 54,032 | 74,044 | 56,279 | | Cost of Revenue | 44,341 | 37,772 | 45,752 | 43,734 | | | Gross Profit | 26,292 | 16,260 | 28,292 | 12,545 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 30,329 | 30,304 | 29,976 | 31,759 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,037) | (14,044) | (1,684) | (19,214) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (132) | (419) |
-
| 1,898 | | Earnings Before Interest And Taxes | (4,169) | (14,463) | (1,684) | (17,316) | | Interest Expense |
-
| (124) | 124 |
-
| | Income Before Tax | (4,169) | (14,339) | (1,808) | (17,316) | | Income Tax Expense | (1,581) | (3,274) | (203) | (4,059) | | Minority Interest |
-
|
-
|
-
| 709 | | | | Net Income From Continuing Ops | (2,588) | (11,065) | (1,605) | (12,548) | | | Non-recurring Events | | Discontinued Operations | (296) | (432) | 512 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,884) | (11,497) | (1,093) | (12,548) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,884) | ($11,497) | ($1,093) | ($12,548) |
|
0.02% Nasdaq 
0.24 (2.46%) 
Income Statement
